Happy Friday! We will miss you, presidential debate season. Only 31 months (give or take) until the first ones of the 2024 cycle!
Quick Hits: Today’s Top Stories
The United States confirmed 74,040 new cases of COVID-19 yesterday per the Johns Hopkins University COVID-19 Dashboard, with 6.5 percent of the 1,139,419 tests reported coming back positive. An additional 1,010 deaths were attributed to the virus on Thursday, bringing the pandemic’s American death toll to 223,000. According to the COVID Tracking Project, 41,010 Americans are currently hospitalized with COVID-19.


All 12 Republican members of the Senate Judiciary Committee voted on Thursday to advance Judge Amy Coney Barrett’s nomination to the Supreme Court; all 10 Democrats on the committee boycotted the vote in protest. The 12-0 vote sets the stage for a full Senate confirmation next week.
Initial unemployment claims fell by 55,000 last week to a seasonally adjusted 787,000, the Labor Department reported Thursday. Slightly more than 23 million people claimed some form of unemployment benefits during the week ending October 3.
According to Amnesty International, at least 56 people have died in Nigeria over the past two weeks amid protests related to police brutality.
In a “60 Minutes” interview set to air Sunday, Joe Biden said he plans to create a “bipartisan commission of scholars” to provide him “recommendations as to how to reform the court system because it’s getting out of whack.” Demand Justice, a liberal group looking to make the judiciary more progressive, called Biden’s proposal a “punt” and said it “runs the risk of stalling momentum for serious reform.”
Following up on the New York Post’s story about Hunter Biden’s ex-business partner Tony Bobulinski and a 2017 planned Chinese energy venture, the Wall Street Journal reports that Joe Biden himself had no role in the endeavor. “The venture—set up in 2017 after Mr. Biden left the vice presidency and before his presidential campaign—never received proposed funds from the Chinese company or completed any deals, according to people familiar with the matter. Corporate records reviewed by The Wall Street Journal show no role for Joe Biden.”
The antiviral drug remdesivir became the first therapeutic to receive full FDA approval for treating COVID-19 on Thursday. The antiviral had been authorized for use on an emergency basis since the spring.
Walmart preemptively sued the federal government on Thursday, in expectation of a legal challenge from the Justice Department alleging that the retail giant’s pharmacists have a track record for filling suspicious opioid prescriptions.
An Actual Debate!

Several weeks ago, only the fiercest of Trump loyalists were able to walk away from the first general election debate and say with a straight face that the president came out on top.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



